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The generation of neurons from neural stem cells re-
quires large-scale changes in gene expression that
are controlled to a large extent by proneural tran-
scription factors, such as Ascl1. While recent studies
have characterized the differentiation genes acti-
vated by proneural factors, less is known on the
mechanisms that suppress progenitor cell identity.
Here, we show that Ascl1 induces the transcription
factor MyT1 while promoting neuronal differentia-
tion. We combined functional studies of MyT1 during
neurogenesis with the characterization of its tran-
scriptional program. MyT1 binding is associated
with repression of gene transcription in neural pro-
genitor cells. It promotes neuronal differentiation
by counteracting the inhibitory activity of Notch
signaling at multiple levels, targeting the Notch1 re-
ceptor and many of its downstream targets. These
include regulators of the neural progenitor program,
such as Hes1, Sox2, Id3, and Olig1. Thus, Ascl1
suppresses Notch signaling cell-autonomously via
MyT1, coupling neuronal differentiation with repres-
sion of the progenitor fate.
INTRODUCTION
The generation of neurons in the developing vertebrate nervous
system requires the progression through a succession of
distinct cellular states. These transitions have been particularly
well characterized in the embryonic telencephalon, where radial
glia (RG) cells located in the ventricular zone (VZ) have character-
istics of neural stem cells and constitute the major progenitor
type during the neurogenic period (Go¨tz and Huttner, 2005).
Upon division, an RG cell can give rise to another RG cell and
either a neuronal committed intermediate progenitor (IP) or a
post-mitotic neuron that migrate toward the subventricular
zone (SVZ) and cortical plate (CP), respectively (Kriegstein and
Alvarez-Buylla, 2009). These events are known to be coordi-
nated, to large extent, by the opposing activities of proneural
and Notch pathways.Ce
This is an open access article under the CC BY-NProneural transcription factors, such as Ascl1 (also known as
Mash1), are both required and sufficient to induce a complete
program of neuronal differentiation (Bertrand et al., 2002; Vas-
concelos and Castro, 2014; Wilkinson et al., 2013). While
activating neuronal differentiation, proneural proteins induce
the transcription of Notch ligands, such as Dll1. Dll1 interacts
with a transmembrane Notch receptor in neighboring cells, re-
sulting in cleavage of the Notch intracellular domain (NICD)
by gamma-secretase and its nuclear translocation, forming a
complex with the DNA-binding transcription factor Rbpj and
additional coactivators. Direct targets of this complex include
the transcriptional repressors Hes1 and Hes5, which repress
the expression of proneural genes and neuronal differentiation
via a process called lateral inhibition (Kageyama et al., 2008;
Louvi and Artavanis-Tsakonas, 2006). The induction of differen-
tiation by proneural factors requires, therefore, the simultaneous
repression of Notch receptor activity in differentiating progeni-
tors by mechanisms that remain poorly understood.
Myelin transcription factor 1 (MyT1 or NZF2) is the founding
member of a family of zinc-finger proteins comprising also
MyT1Like (MyT1L or NZF1) and MyT3 (NZF3 or St18) (Jiang
et al., 1996; Kim and Hudson, 1992; Yee and Yu, 1998). All fac-
tors are expressed with distinct patterns throughout the mouse
developing nervous system. In situ hybridization studies have
described Myt1 expression in differentiating progenitors and
post-mitotic neuronal precursors, in both CNS and peripheral
nervous system, starting at the beginning of the neurogenesis
period (Matsushita et al., 2002, 2014). Evidence for a regulatory
function of MyT1 in a neurogenic context was provided by func-
tional studies in Xenopus embryos, where it counteracts lateral
inhibition in synergy with the proneural factors X-Ngnr1, Xash3,
or Xath5 (Bellefroid et al., 1996; Quan et al., 2004; Schneider
et al., 2001). In mouse, the analysis of MyT1-null embryos has
failed to provide insights into the function of MyT1 in the nervous
system, presumably due to the observed ectopic upregulation of
other family members in this mouse model (Hudson et al., 2011;
Wang et al., 2007). More recently, the extensive use of MyT1L in
neuronal reprogramming of mouse and human somatic cells
(e.g., Pang et al., 2011 and Vierbuchen et al., 2010) has renewed
the interest in understanding the function of MyT1 and its related
factors in vertebrate neurogenesis.
Here, we identify MyT1 as a direct target of the proneural
factor Ascl1 at the onset of neuronal differentiation, and well Reports 17, 469–483, October 4, 2016 ª 2016 The Author(s). 469
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investigate the function of MyT1 at this critical stage by
combining acute functional experiments in the mouse telen-
cephalon with the characterization of its transcriptional program.
We found that MyT1 binding occurs mostly at active regulatory
regions in undifferentiated neural stem/progenitor cells and is
associated with transcriptional repression genome-wide. We
further show that MyT1 acts at multiple levels to antagonize
the inhibitory activity of Notch signaling, targeting both Notch
pathway components and downstream targets. Notably, MyT1
promotes the downregulation of Hes1, a determinant step for
the onset of neurogenesis, by competing with Rbpj for binding
to theHes1 promoter. Our results reveal a function of Ascl1 in in-
hibiting Notch signaling cell-autonomously, showing how activa-
tion of neuronal differentiation is tightly coordinated with repres-
sion of the progenitor program.
RESULTS
Ascl1 Directly Activates the Transcription Factor MyT1
Several observations have suggested the zinc-finger transcrip-
tion factor MyT1 may be under the regulation of Ascl1. Specif-
ically, Myt1 expression is increased or decreased in expression
profiling studies using DNA arrays upon Ascl1 gain and loss of
function (GoF and LoF), respectively, both in mouse cultured
neural stem/progenitor cells and in the embryonic telencephalon
(Figure S1) (Castro et al., 2011; Gohlke et al., 2008; Raposo et al.,
2015).
We started by analyzing the kinetics ofMyT1 expression, using
a cellular model of neurogenesis in which differentiation is trig-
gered by the activation of an inducible version of Ascl1 protein
(Ascl1-ERT2) in the neural stem cell line NS5 with 4-hydroxy-
tamoxifen (Tam) (Raposo et al., 2015). Upon Ascl1 induction,
MyT1 protein levels increased, as measured by immunocyto-
chemistry and western blot (Figures 1A and 1B). Co-localization
of MyT1 with the neuronal marker B-III-Tubulin (TuJ1) indicated
that MyT1 expression occurred in differentiating neurons (Fig-
ure 1A). The increase in Myt1 expression occurred after the in-
crease in Dll1 transcript, an early Ascl1 target gene, and pre-
ceded the increase in B-III-Tubulin transcript, an early neuronal
marker that is also directly activated by Ascl1 (Castro et al.,
2006, 2011) (Figure 1C). Thus, the timing of MyT1 induction is
consistent with MyT1 being directly controlled by Ascl1.Figure 1. MyT1 Is a Direct Target of Ascl1 during Neuronal Differentiat
(A) Immunocytochemical analysis of MyT1 (green) and TuJ1 (red) before (Tam)
Scale bar, 50 mm.
(B) Analysis of MyT1 protein levels by western blot post-Tam induction. a-tubulin
(C) RNA expression analysis of Myt1, Dll1, and B-III-Tubulin by qPCR post-Tam
(D) Ascl1 (black), H3K27ac (green), and H3K4me1 (blue) ChIP-seq and DNase-s
entiating NS cells. MyT1 prom_Fw and MyT1 prom_Rv indicate genomic locatio
(E) ChIP-qPCR of Ascl1 in chromatin extracted from E12.5 ventral telencephalon
amplified using the primers highlighted in (D).
(F) Immunohistochemical analysis for MyT1 (green) and neuronal marker B-III-Tub
sections of E14.5 mouse telencephalon is shown. Scale bar, 100 mm.
(G) Immunohistochemical analysis for MyT1 (green), Ascl1 (red), and TuJ1 (cya
indicate magnified regions of VZ and SVZ. White arrowheads indicate co-localiz
(lower panel). VZ, ventricular zone; SVZ, subventricular zone. Scale bar, 100 mm
Data are shown as mean ± SD; n.s., p > 0.05; **p < 0.01, ***p < 0.001, and ****p <
testing (C) and Student’s t test (E). See also Figure S1.Effectively, visual inspection of the chromatin immunoprecipi-
tation followedbydeep sequencing (ChIP-seq) enrichment profile
of Ascl1-ERT2 in differentiating cells identified several peaks, cor-
responding to Ascl1 binding to active enhancer regions enriched
for H3K4me1 and H3K27ac in the vicinity of the MyT1 gene (Fig-
ure 1D). Some Ascl1-binding events (BEs) occurred in closed
chromatin regions in proliferating progenitors, which became
opened during neuronal differentiation, as assessed by DNase
sequencing (DNase-seq) (Figure 1D). This feature is associated
with Ascl1 targets that are expressed de novo during differentia-
tion (Raposo et al., 2015), and it may account for the late timing
of MyT1 induction after Ascl1 expression. Ascl1 binding to Myt1
promoter was further validated by ChIP-qPCR in chromatin ex-
tracted from the developing ventral telencephalon (Figure 1E).
MyT1 Promotes Neurogenesis in the Mouse
Telencephalon
Myt1 transcript is expressed in the germinal layers during the
neurogenic period in scattered cells in the VZ, with highest
expression in the SVZ (Matsushita et al., 2002, 2014). In the
ventral telencephalon, MyT1 protein expression domain largely
overlapped with that of the neuronal marker TuJ1 (Figure 1F).
At the cellular level, many, but not all, MyT1-expressing cells in
the SVZ co-expressed TuJ1 (Figure 1G), suggesting MyT1 was
expressed both in IPs and differentiating neurons. In addition,
few MyT1-expressing cells were interspersed in the VZ co-ex-
pressing TuJ1 (Figure 1G, arrowheads in upper panels). Although
MyT1 and Ascl1 expression domains were mostly non-overlap-
ping (Figure 1F), some cells co-expressing both factors could
be found in the SVZ (Figure 1G, arrowheads in bottom panels),
as expected from Ascl1-expressing IPs. Overall, the expression
pattern was consistent with MyT1 starting to be expressed at the
transition from RG cells to differentiating neurons, either directly
(VZ) or indirectly through the generation of IPs (SVZ). The persis-
tent expression of MyT1 in post-mitotic neuronal precursors
suggests a function also at later stages of neurogenesis.
We next investigated MyT1 function in the telencephalon by
performing acute GoF and LoF experiments by in utero electro-
poration. We targeted the lateral ganglionic eminence (LGE) at
embryonic day (E)12.5, a stage at which MyT1 is the only mem-
ber of its family to be significantly expressed in germinal layers
(Matsushita et al., 2002, 2014). MyT1 overexpression resultedion
and 48 hr after Tam induction (+Tam). Cell nuclei are labeled with DAPI (blue).
was used as a loading control.
induction is shown.
eq enrichment profiles (yellow) at Myt1 locus in undifferentiated and/or differ-
ns of primers used in (E).
is shown. ORF1, negative control region; MyT1 prom., Myt1 promoter region
ulin (TuJ1, red) (left panel) or MyT1 (green) and Ascl1 (red) (right panel) in frontal
n) in frontal sections of E14.5 mouse ventral telencephalon. Dashed squares
ation of MyT1 and TuJ1 in the VZ (upper panel) or MyT1 and Ascl1 in the SVZ
.
0.0001, according to one-way ANOVA with Bonferroni correction for multiple
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Figure 2. MyT1 Promotes Neurogenesis in
the Developing Telencephalon
(A) Analysis by western blot of MyT1 in P19 cells co-
transfected with MyT1 expression vector, scramble
shRNA (shControl), and/or MyT1 shRNA (shMyT1).
a-tubulin was used as a loading control.
(B and C) In utero electroporation of control or
MyT1-, control shRNA- (shControl), orMyT1 shRNA-
(shMyT1) expressing vectors in E12.5 mouse ventral
telencephalon. Immunofluorescence analysis on a
coronal section of the telencephalon for GFP (green
or gray) and TuJ1 (red) 2 days post-electroporation
(E14.5) is shown. Cell nuclei are labeled with DAPI
(blue). Histograms represent the quantification of VZ
to SVZ transition based on the fraction of GFP+ cells
that are retained in the VZ (GFP+VZ/GFP+) (B) and
of neuronal differentiation based on the fraction of
GFP+ cells that express TuJ1 ((TuJ1+GFP+)/GFP+)
(C). VZ, ventricular zone; SVZ, subventricular zone.
Scale bars, 20 and 50 mm (B and C).
Data are shown as mean ± SD; **p < 0.01, ***p <
0.001, and ****p < 0.0001, according to Student’s
t test (B and C). See also Figure S2.in more cells (56% increase) leaving the VZ, and this was asso-
ciated with an increase in TuJ1-expressing cells (20% more)
when compared to control conditions (Figures 2B and 2C). By
contrast, knockdown of MyT1 with a small hairpin RNA (shRNA)
expression vector (ShMyT1) (Figure 2A) resulted in more cells re-
maining in the VZ (85% increase) and fewer TuJ1-positive cells
(17.4% decrease) (Figures 2B and 2C). We analyzed if the
concomitant induction of other family members could be
compensating the extent of the phenotype observed, by knock-
ing down MyT1 together with MyT1L or MyT3. Indeed, a signifi-
cant enhancement of the phenotype was observed when
combining shMyT1 with shMyT1L, both in number of cells re-
tained in the VZ and in the number of TuJ1-positive cells (Fig-
ure S2); the combination with ShMyT3 did not increase signifi-
cantly the phenotype triggered by shMyT1 alone. Altogether,
these experiments demonstrate that MyT1 promotes neurogen-
esis in the developing mouse embryo.
MyT1 Functions as a Transcriptional Repressor during
Neurogenesis
To understand the molecular basis of MyT1 function at the onset
of differentiation, we characterized its target genes upon acute
GoF in neural stem/progenitor cells. For this, we infected NS5
cells with a lentivirus expressing a doxycycline (Dox)-inducible
HA-tagged version of MyT1, and we characterized the gene
expression changes 4 hr post MyT1 induction using DNA arrays
(Figure S3). This identified 1,764 deregulated genes (p < 0.05),
of which 57% were downregulated and 43% were upregulated
(Table S1). We performed genome-wide mapping of MyT1
binding by ChIP-seq using an antibody against the HA-tag of472 Cell Reports 17, 469–483, October 4, 2016MyT1, and we identified 7,615 BEs (q <
102) associated with 4,448 unique genes
following a nearest gene annotation (Table
S2). A de novo search found the MyT1-
binding motif (Gamsjaeger et al., 2008;Kim and Hudson, 1992) to be enriched at peak summits, with
peaks with one or multiple motifs significantly enriched when
compared to a control dataset (Figures 3A–3C). In addition, a
compound Rfx/Rbpj motif, E box (bHLH) and Sox DNA-binding
motifs were also overrepresented. Hierarchical clustering of
MyT1 peaks according to the presence of these motifs revealed
their occurrence was largely mutually exclusive (Figure S4A).
Although the largest group bore the MyT1 motif, the data sug-
gest that many MyT1 peaks result from indirect recruitment of
MyT1 by other TFs.
Previous reports have implicated MyT1 both in transcriptional
activation and repression (Bellefroid et al., 1996; Hu et al., 2013;
Romm et al., 2005; Wang et al., 2008; Yokoyama et al., 2014). To
gain an insight into the global transcriptional response mediated
by MyT1, we integrated the location analysis of MyT1 with the
expression profiling to find that 14% of sites are associated
with a deregulated gene. Strikingly, MyT1 BEs were statistically
significantly associated with downregulated genes (p < 3.45 3
1051), whereas such association with upregulated genes was
not found (Figure 3D). Notably, this differential association with
downregulated genes was maintained when considering only
peaks containing theMyT1motif, or thosewithout it (Figure S4B),
suggesting that all types of MyT1 BEs are associated with
repression of gene expression.
We next determined the fractions of up- and downregulated
genes associated with at least one MyT1 BE (direct targets),
considering increasing p value cutoffs for MyT1 binding (Fig-
ure 3E). We found that downregulated genes were strongly en-
riched for MyT1 direct targets, in contrast to upregulated genes
(Figure 3E, compare Down/MyT1 with Up/MyT1), and that such
(legend on next page)
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enrichment was statistically significant (Figure 3E, compare
Down/MyT1 with Down/Random), confirming that MyT1 binding
is associated with gene repression genome-wide.
Genome-wide maps of histone modifications in proliferating
NS5 cells (Mikkelsen et al., 2007; Raposo et al., 2015) showed
significant enrichment of H3K27ac, H3K4me1, and H3K4me3
at MyT1 BEs, as compared to random genomic regions (while
no enrichment of the repressive mark H3K27me3 was found)
(Figure 3F). In addition, most MyT1 BEs were found within inter-
genic or intronic regions, with a smaller but significant fraction
occurring at gene promoters (Figure 3G). These results suggest
that MyT1 binds to distal enhancer and promoter regions
bearing active marks in neural stem/progenitor cells, and they
are in line withMyT1’s role as a transcriptional repressor at onset
of differentiation.
MyT1 Represses Notch Pathway Components and
Regulators of the Neural Progenitor Program
We next assessed the expression of the identified MyT1 targets
(bound and downregulated) at distinct stages of the neuronal
lineage, using expression profiling datasets representative of
various layers of the E14.5 mouse embryonic cortex (Fietz
et al., 2012). Notably, most MyT1 direct targets (69.0%) were
downregulated during neuronal differentiation in vivo, as indi-
cated by a decrease in expression from VZ to SVZ or CP (Fig-
ure 3H). In addition, their absolute levels of expression were
highest at VZ, when compared to SVZ and CP (Figure 3I).
To investigate the function of MyT1 direct targets, we per-
formed gene ontology (GO) analysis on a high-confidence list
of 402 MyT1 targets (bound and repressed by MyT1) (Table
S3). Enriched terms (GO biological processes) suggested a
role in maintenance of a progenitor state (negative regulation
of neuron differentiation, positive regulation of cell proliferation,
and cell-cycle process), and they were associated with NotchFigure 3. MyT1 Binding Represses Neural Progenitor Genes
(A) Top overrepresented motifs in 50-bp regions centered at MyT1 peak summit
(B) Frequency distribution of MyT1 motif centered at MyT1 peak summits (blue) or
50 bp.
(C) Fold enrichment of MyT1 peaks with distinct number of MyT1 motifs as comp
(D) Number of MyT1 BEs associated with up- (blue bar) or downregulated (red bar)
significance was assessed by comparing the association with 1,000 randomize
represented as box with median of test and first and third quartiles. Whiskers, ±
(E) Heatmap displaying the cumulative fraction of deregulated genes in MyT1 Go
FC > 1.2 are plotted against MyT1 BEs with increasing p value (bin = 94 BE
100 randomly generated ChIP-seq datasets of equal size.
(F) ChIP-seq enrichment profiles of histone marks in undifferentiated NS5 cells, in
enrichment profile of histone marks at random genomic regions.
(G) Pie chart represents the fraction of MyT1 BE overlapping gene features.
(H) Heatmap representing the expression of MyT1 direct targets (bound and down
code refers to relative gene expression levels. Hierarchical clustering was done us
in the graph above. VZ, ventricular zone; SVZ, subventricular zone; CP, cortical
(I) Absolute expression levels (fragments per kilobase per million mapped reads [
telencephalon. Data distribution is represented as box with median and first and
(J) Enrichment of representative GO biological process terms associated with M
(K) Validation of MyT1 binding to selected genes by ChIP-qPCR with anti-HA anti
regions. Mean ± SD of triplicate assays.
(L) Validation of gene expression changes of selected genes in NS5 cells 4 hr up
(M) ChIP-qPCR using anti-LSD1 antibody in NS5 cells before (Dox) and 4 hr af
Data are shown asmean ±SD; n.s., p > 0.05; *p < 0.05, **p < 0.01, ***p < 0.001, and
474 Cell Reports 17, 469–483, October 4, 2016pathway genes (e.g., Notch1, Lfng, Dtx4, and Hes1) (Figure 3J;
Table S4). In addition, MyT1 targets encoded important tran-
scriptional regulators (regulation of transcription from RNA
polymerase II [Pol II] promoter) (Figure 3J) of the neural progen-
itor program, such as Sox2, Id3, and Olig1 (Bai et al., 2007;
Englund et al., 2005; Go´mez-Lo´pez et al., 2011) (Figures 3K
and 3L; Table S4).
MyT1 has been shown to physically interact with the histone
demethylase LSD1 in a complex that contains CoREST and pro-
motes transcriptional repression (Yokoyama et al., 2014). To
address if LSD1 is recruited by MyT1 to the abovementioned
targets associated with a MyT1 motif, we performed anti-LSD1
ChIP-qPCR. We observed a substantial increase of LSD1
recruitment to MyT1 target sites upon MyT1 GoF, supporting a
role for this histone demethylase in MyT1-mediated transcrip-
tional repression in neural progenitor cells (Figure 3M).
MyT1 Promotes Neurogenesis by Counteracting
Notch-Signaling Activity
Given the prominence of Notch-related genes among MyT1 tar-
gets and in line with previous findings (Bellefroid et al., 1996; Hu
et al., 2013; Romm et al., 2005; Wang et al., 2008; Yokoyama
et al., 2014), we tested if MyT1 can counteract the inhibitory ef-
fect of Notch signaling in neurogenesis. We infected NS5 cells
with lentiviruses expressing Ascl1, MyT1, and a membrane-
bound dominant active version of the Notch1 receptor, whose
cleavage is independent of a ligand/receptor interaction (Act
Notch). As expected, Ascl1 expression induced the generation
of TuJ1-positive neurons with a concomitant decrease of Sox2
expression (Berninger et al., 2007; Farah et al., 2000; Nakada
et al., 2004), and this effect was inhibited by the co-expression
of Act Notch (Gaiano et al., 2000) (Figure 4A). Importantly,
MyT1 alone did not trigger neuronal differentiation, but its co-
expression with Ascl1 overcame the inhibition by Act Notch, ass are shown. Z, Z score; R, enrichment ratio.
2 kb upstream (control, gray). y axis represents the number of motifs in bins of
ared to control regions is shown.
genes following a nearest gene annotation inMyT1 GoF DNA arrays. Statistical
d datasets of equal size and assuming a normal distribution. Test data are
1.53 interquartile range (IQR).
F that are directly regulated by MyT1. Number of transcripts with expression
s). Statistical significance was assessed by comparing the association with
4-kb genomic regions centered at MyT1 peak summits. Dashed lines show the
regulated) in distinct layers of the E14.5mouse embryonic telencephalon. Color
ing Pearson correlation. Absolute levels of expression of MyT1 are represented
plate.
FPKM]) of MyT1 direct targets in distinct layers of the E14.5 mouse embryonic
third quartiles (whiskers, ±1.53 IQR; notches, ±1.53 IQR/n1/2).
yT1 targets (genes bound and downregulated by MyT1) is shown.
body in NS5 cells upon MyT1 GoF is shown. ORF1 and ORF2, negative control
on MyT1 GoF by expression qPCR is shown. Mean ± SD of triplicate assays.
ter (+Dox) MyT1 GoF is shown. ORF1 and ORF2, negative control regions.
****p < 0.0001, according to Student’s t test (K–M). See also Figures S3 and S4.
(legend on next page)
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observed by a rescue of the number of TuJ1-positive cells to
levels similar to those obtained with Ascl1 alone (with Sox2
expression following a similar trend). In addition, a strong in-
crease in the differentiation activity of Ascl1 alone was observed
when both factors (Ascl1 + MyT1) were co-expressed (Figures
4A and 4B, respectively). Altogether, our results suggest that
MyT1 alone is not able to promote neuronal differentiation but
that it enhances the activity of the proneural factor by counter-
acting the inhibitory activity of the Notch pathway.
We next tested whether MyT1 could similarly counteract
Notch signaling in vivo by co-electroporating MyT1 and Act
Notch expression vectors in the dorsal telencephalon. As ex-
pected, expression of Act Notch inhibited endogenous neuro-
genesis, resulting in the retention of electroporated cells closer
to the ventricular surface and in a decreased number of cells
expressing the neuronal marker Satb2 (Figures 4B and 4C),
whereas MyT1 overexpression had the opposite effect (Figures
4B and 4C). Notably, co-expression of Act Notch and MyT1
rescued significantly the Act Notch phenotype (Figures 4B and
4C). Overall, these experiments support the conclusion that
MyT1 counteracts Notch signaling during neurogenesis.
MyT1 Counteracts Notch Activation of Hes1 Expression
Considering the well-established role of Hes1 as a downstream
effector of Notch signaling in neurogenesis (Artavanis-Tsakonas
et al., 1999; Shimojo et al., 2008), we next focused on the regu-
lation of this MyT1 target gene. Analysis of the MyT1 ChIP-seq
profile showed strong enrichment at theHes1 proximal promoter
region, centered on three evolutionarily conserved MyT1 motifs
(Figure 5A). Strikingly, these motifs were found in tandem, and
partially overlapping, with three Rbpj-binding motifs (TC box)
previously shown to mediate the regulation of Hes1 by Notch/
Rbpj (Arnett et al., 2010; Jarriault et al., 1995; Nam et al., 2007)
(Figure 5B). To test the ability of MyT1 to bind to its cognate mo-
tifs, we performed an electrophoretic mobility shift assay (EMSA)
using a Hes1 oligonucleotide probe spanning the MyT1motifs or
mutated versions. MyT1 was able to directly bind to this Hes1
promoter probe, as shown by the formation of a large DNA/
protein complex (Figure 5C). The formation of this complex
was strongly reduced or abolishedwhen each of theMyT1motifs
was disrupted separately or simultaneously, respectively, sug-
gesting cooperative binding of MyT1 to the three sites.
We next investigated whether MyT1 could counteract the ac-
tivity of Notch signaling on a luciferase reporter construct con-
taining the Hes1 proximal promoter region spanning all MyT1
and Rbpj sites (pHes1::Luc) (Nishimura et al., 1998). A transcrip-
tional assay in transfected P19 cells showed Act Notch stronglyFigure 4. MyT1 Counteracts Inhibition of Neuronal Differentiation by N
(A) Immunocytochemical analysis of Sox2 (red) and TuJ1 (green) upon infection w
Dox. Nuclei were labeled with DAPI (blue). Histograms represent the percentage
(B and C) In utero electroporation of control or MyT1, Act Notch, or Act Notch +
rescence analysis of coronal sections of GFP (green) and the neuronal marker Satb
DAPI (blue). Scale bars, 500 mm (B) and 50 and 20 mm (C, left and right). (B’) Histogr
from ventricular to pial surface, respectively) of equal length spanning the cortic
cells in each condition. Arrowheads indicate examples of Satb2+GFP+ cells. Arro
Data are shown as mean ± SD; n.s., p > 0.05; *p < 0.05, **p < 0.01, ***p < 0.001, a
multiple testing (A) and Student’s t test (B’–C’).
476 Cell Reports 17, 469–483, October 4, 2016activates the Hes1 promoter, while co-expression of MyT1
completely abrogated this activity (Figure 5D). To test if the
observed effect of MyT1 is dependent on DNA binding, we per-
formed mutagenesis on the MyT1-binding sites. Mutations were
designed so as tominimize any effect onNotch activation, result-
ing in promoter constructs that still responded, albeit less
strongly, to Act Notch (Figure 5E). Disruption of individual bind-
ing sites partially impaired the activity of MyT1 (Figure 5F), while
simultaneous disruption of the three sites (BS1 + 2 + 3) had a
stronger effect readily observed when lower ratios of MyT1/Act
Notch were used (Figure 5G). Similar results were obtained using
a dominant active version of Rbpj fused to the VP16 activation
domain (RBPJ-VP16) (Figure 5H), further supporting that MyT1
regulates Hes1 at the promoter level. Importantly, no other tran-
scription factor tested was able to counteract Act Notch activity
on Hes1 promoter (Figure S5). Altogether, we concluded that
MyT1 counteracts the activity of the Notch/Rbpj complex on
the Hes1 promoter via a mechanism that depends on binding
to the three MyT1-binding sites.
Next, we analyzed MyT1 protein and Hes1 transcript expres-
sion patterns in the embryonic mouse telencephalon by double
immuno/in situ hybridization, andwe concluded these are largely
non-overlapping (Figure 6A). To further investigate this with sin-
gle-cell resolution, we re-examined the molecular signatures of
96 E11.5 dorsal telencephalic neural stem/progenitor cells ob-
tained by single-cell RNA sequencing (RNA-seq) (Hagey and
Muhr, 2014). Profiling using principal component 2 (PC2), which
orders cells through differentiation according to markers that
reflect the progression of cortical neurogenesis (Hagey and
Muhr, 2014), showed an inverse correlation between Myt1 and
Hes1 expression (Figure 6B, upper graph), with a Spearman
correlation coefficient of reads per kilobase per million mapped
reads (RPKM) levels of 0.407. In spite of this, examination
of absolute RPKM levels showed that co-expression of both
genes was detected in a small but significant fraction of cells,
suggesting the onset ofMyt1 expression occurs in cells that still
express Hes1 (Figure 6B, bottom panel). Thus,MyT1 expression
is inversely correlated, but partially overlapping, with that of
Hes1, which is consistent with MyT1 playing a determinant role
in switching off Hes1 transcription at the onset of neurogenesis.
MyT1 Represses Many Notch/Rbpj Transcriptional
Targets
The overrepresentation of a putative Rbpj-binding motif at MyT1
target sites (Figure 3A) suggests the direct control of Notch
target genes by MyT1 may extend beyond the regulation of
Hes1. To investigate this, we compared the transcriptionalotch Signaling
ith control or Ascl1-, Act Notch-, and/or MyT1-inducible lentiviruses 48 hr post-
of Sox2+/DAPI or TuJ1+/DAPI cells in each condition. Scale bar, 40 mm.
MyT1 expression vectors in E13.5 mouse dorsal telencephalon. Immunofluo-
2 (red) 5 days after electroporation (E18.5) is shown. Cell nuclei are labeled with
am represents the percentage of electroporated cells present in five bins (1 to 5
al thickness. (C’) Histogram represents the percentage of (Satb2+GFP+)/GFP+
ws indicate examples of Satb2GFP+ cells.
nd ****p < 0.0001, according to one-way ANOVA with Bonferroni correction for
Figure 5. MyT1 Counteracts the Activity of
Rbpj/Notch at the Hes1 Promoter
(A) MyT1 (blue) and RBPJ (red) ChIP-seq enrichment
profiles at the vicinity of Hes1 gene. Regions con-
tained in Hes1::Luc and EMSA probe are indicated
below figure.
(B) Species alignment of Hes1 proximal promoter
region spanning MyT1 (blue) and Rbpj (red) binding
motifs is shown.
(C) EMSA shows MyT1 binding to a Hes1 promoter
probe with wild-type (WT) sequence or mutations in
MyT1 binding sites. n.s., non-specific band.
(D–G) Transcriptional assay in P19 cells co-trans-
fected with control or MyT1 and/or Act Notch
expression vectors and a reporter construct
expressing luciferase under the control of Hes1
proximal promoter region (pHes1::Luc) or mutated
versions in which MyT1-binding sites were individ-
ually or simultaneously disrupted. Equal amounts
of expression vectors were used, except in (G) in
which the various MyT1:ActNotch ratios used are
indicated. Mean ± SD of quadruplicate assays.
(H) Transcriptional assay in P19 cells co-trans-
fected with a control or MyT1 and/or RBPJ-VP16
(Blanpain et al., 2006) expression vectors together
with pHes1::Luc is shown.
Data are shown as mean ± SD; n.s., p > 0.05; *p <
0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001,
according to Student’s t test (F and G) or one-way
ANOVA test with Bonferroni correction for multiple
testing (D, E, and H). See also Figure S5.changes observed in our MyT1 GoF model with those that take
place upon exposure of NS5 cells to the pharmacological inhib-
itor of gamma-secretase LY411575 (LY), (Lanz et al., 2004), as
assessed by RNA sequencing (RNA-seq) (Table S5). When
considering a high-confidence list of genes deregulated upon
MyT1 induction (p < 0.01, n = 90), the vast majority (81%) was
also deregulated upon LY treatment, with all these but two genes
changing in the same direction (Figure 7A). Notably, this same
trend (expression of common deregulated genes changes in
same direction) was maintained when decreasing the stringency
cutoff for deregulation by MyT1 (p < 0.05, n = 1,612), or simulta-Ceneously increasing the stringency cutoff for
deregulation upon LY treatment (q < 0.01,
n = 1,612) (Figure 7A). Thus, MyT1 expres-
sion induces a global change in gene
expression that resembles that triggered
by the inhibition of Notch signaling.
Considering the short time points (4 hr)
at which both expression profiling experi-
ments were performed, it is likely that
many genes downstream Notch are direct
MyT1 targets. In agreement with this, we
found a much stronger statistical associa-
tion of MyT1 BEs with genes downregu-
lated by LY than with upregulated ones
(p < 1.63 1070 versus p < 1.13 108) (Fig-
ure 7B). To evaluate the extent to which
MyT1 represses genes directly activatedby the Notch/Rbpj complex, we performed genome-wide map-
ping of Rbpj in NS5 cells by ChIP-seq, resulting in the identifica-
tionof 15,281BEs (q<102) (TableS6; Figure 7D) associatedwith
9,215 unique genes. As expected, a de novo search for DNAmo-
tifs enriched at Rbpj BEs found the TC box to be the most en-
riched motif, in addition to an E box (bHLH) and the compound
Rfx/Rbpj motif (Figure 7C). A strong Rbpj-sequencing signal
was found at genomic regions centered at MyT1 peak summits,
confirming that MyT1 often binds in close vicinity to Rbpj (Fig-
ure 7E), as illustrated for several targets (Figures 5A and 7D).
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Figure 6. Comparative Analysis of MyT1 and Hes1 Expression in
Neural Progenitor Cells
(A) Immunofluorescence of MyT1 (green) and in situ hybridization for Hes1
(gray) in frontal sections of E14.5 mouse embryonic telencephalon. Dashed
squares indicate magnified regions of dorsal (middle) or ventral (bottom
panels) domains. Scale bar, 140 mm.
(B) Top panel: relative expression of Myt1 and Hes1 in 96 E11.5 dorsal telen-
cephalic neural progenitor cells, determined by single-cell RNA-seq. Dots
represent rolling averages, ordered by principal component 2 (PC2), with
polynomial trend lines overlapping. Bottom panel: absolute expression levels
of Myt1 and Hes1 in neural progenitor cells are shown as above, ordered by
MyT1 expression levels.also bound by Rbpj. MyT1 and RBPJ binding and their opposite
effects in target gene expressionwere validated for several genes
(Figures 3K, 3L, 7F, and 7G). Most significantly was the ability of478 Cell Reports 17, 469–483, October 4, 2016both pathways to oppositely regulate the expression of Notch1,
further validated by the ability of MyT1 to counteract the activa-
tion of Notch1 gene promoter by Act Notch in a transcriptional
assay (Figures S6A–S6C). In conclusion, MyT1 can counteract
the Notch pathway at distinct levels, repressing Notch-signaling
components and many of its downstream targets.
DISCUSSION
In spite of its identification two decades ago, little progress has
been made toward understanding the function of the zinc-finger
factor MyT1 in vertebrate neurogenesis. After initial studies in
Xenopus embryos suggested X-MyT1 promotes neurogenesis
by counteracting lateral inhibition (Bellefroid et al., 1996), a
confirmation of such model using mouse genetics has been
hampered by functional redundancy with other family members
(Wang et al., 2007). In addition, nomolecular basis has been ever
established for MyT1 function, to large extent due to the lack of
identified target genes. Here we provide evidence of a neuro-
genic role for MyT1 in the developing mouse embryo, and we
characterize its transcriptional program.
Activation of neuronal differentiation requires the concomitant
repressionof thegeneexpressionprogram that operates in neural
stem/progenitor cells, including the downregulation of the Notch
transcriptional program (Imayoshi and Kageyama, 2014; Ka-
geyama et al., 2008). This is often attributed to decreased Notch
input signaling from neighboring cells (Kawaguchi et al., 2008;
Nelson et al., 2013), which results in default repression of Notch
target genes via the recruitment of corepressors by Rbpj. How-
ever, recent studies have reported that IPs exhibit attenuated
Rbpj signaling as compared to RG cells, and they are unable to
induce the expression of Hes genes upon activation of the Notch
receptor (Kawaguchi et al., 2008; Mizutani et al., 2007; Nelson
et al., 2013). This suggests the existence of cell-autonomous
mechanisms to inhibit the Notch program at the onset of differen-
tiation, which could be explained by the regulation of Notch
target genes by transcription factors such as MyT1. In addition,
MyT1 interacts with the Notch pathway also by regulating various
pathway components.Most notably, the repression ofNotch1 re-
ceptor gene may lead to an overall decrease of Notch-signaling
levels by MyT1. In agreement with this, the expression of Hes5,
awell-established readoutofNotchsignaling,wasstronglydown-
regulated upon MyT1 expression with no apparent binding of
MyT1 to its promoter region (Figures 3L, S6D, and S6E).
Among the targets identified, Hes1 is likely to be a major
effector of MyT1 in neurogenesis. Hes1 expression intrinsically
oscillates in proliferating neural stem/progenitor cells, by a
mechanism that relies on its activation by Notch signaling. It is
believed that the onset of differentiation depends critically on
the sustained downregulation of Hes1 expression; however,
the mechanisms that repress Hes1 in this context are poorly un-
derstood (Imayoshi and Kageyama, 2014; Imayoshi et al., 2013).
The cis architecture of theHes1 promoter, where MyT1 and Rbpj
sites are found interspersed and partially overlapping, was re-
vealed to be a very efficient mechanism to counteract Notch ac-
tivity. This feature may be unique to Hes1, as we did not find a
similar cis architecture at other regulatory regions targeted by
both pathways.
Figure 7. MyT1 and Notch Pathways Oppositely Regulate Many Transcriptional Targets
(A) Pie charts representing the percentage of genes deregulated in NS5 cells 4 hr upon MyT1 GoF and deregulated in the same direction (green), opposite di-
rection (red), or unchanged/data unavailable (gray) 4 hr upon LY treatment. Cutoff values for analysis upon MyT1 GoF (p value) and exposure to LY (q value) are
indicated in figure next to each pie chart. n, total number of genes.
(B) Number of MyT1 BEs associated with genes that are up- (blue bar) or downregulated (red bar) upon LY treatment. Boxplot distributions of MyT1-binding
associations, which can be found testing against 1,000 different random sets of genes, are shown. Test data are represented as box with median of test and first
and third quartiles (whiskers, ±1.53 IQR).
(legend continued on next page)
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It has been shown that MyT1L cooperates with Ascl1 in re-
programming mouse embryonic fibroblasts (MEFs) into induced
neurons (Vierbuchen et al., 2010). Although it is not clear what
the levels of canonical Notch signaling are in MEFs, Hes1
expression is well documented in this cellular context. MyT1
family members have high sequence homology within the
zinc-finger domains, and all have been shown to recognize the
MyT1 DNA-binding motif (Bellefroid et al., 1996; Jiang et al.,
1996; Yee and Yu, 1998). Therefore, it is possible that MyT1L
functions, at least in part, by repressing Hes1 during reprogram-
ming. In support of this, we found that MyT1L counteracts
the Notch activation of Hes1 promoter with the same efficiency
as MyT1 (Figure S7A). In addition, ChIP-qPCR analysis of an
HA-tagged version of MyT1L revealed a strong enrichment
at Hes1 proximal promoter soon after ectopic expression in
MEFs (Figure S7B).
The broad expression of MyT1 in the embryonic nervous sys-
tem (Matsushita et al., 2014), together with the importance of
Notch signaling in neurogenesis, suggests that the regulatory
events we identified in the telencephalon may occur pan-neuro-
nally throughout the embryonic nervous system. In addition,
while our study focuses on the function of MyT1 at the onset of
neuronal differentiation, further research should also address
the function of MyT1 at later stages along the neuronal lineage.
EXPERIMENTAL PROCEDURES
Immunohistochemistry and In Situ RNA Hybridization
Embryonic brains were processed for in situ hybridization or immunostaining
as previously described (Castro et al., 2011). For double in situ hybridization/
immunohistochemistry, frozen sections were treated as for in situ hybridization
until the last post-fixation step, before immunostaining. The Hes1 probe was
produced from the plasmid pBluescriptII SK-Hes1. NS5 cells were grown on
glass coverslips coated with poly-L-Lysine (Sigma-Aldrich) and fixed with
4% formaldehyde for 10 min. See the Supplemental Experimental Procedures
for antibody dilutions used. Bright-field and fluorescent images of fixed sec-
tions and coverslips were acquired using the microscope Leica DMRA2 or
the laser-scanning confocal microscope Zeiss LSM510 Meta.
In Utero Electroporation
MouseMyT1 cDNA (Nielsen et al., 2004) and AcNotch coding sequences were
cloned upstream of an internal ribosomal entry site (IRES) and an nuclear local-
ization signal (NLS)-tagged GFP in the pCAG expression vector (Niwa et al.,
1991). Control and shRNA plasmids used (Sigma-Aldrich) were pLKO.1
scramble shRNA (Addgene 1864), pLKO MyT1 shRNA (TRCN0000081610),
pLKO MyT1L shRNA (TRCN0000012109), and pLKO MyT3 shRNA
(TRCN0000042479). Electroporation in utero was employed at E12.5 or
E13.5 to deliver expression vectors (1 ml DNA plasmid corresponding to 3 mg
mixed with 0.03% fast-green dye in PBS) to the ventricular RG cells of mouse
embryos, as previously described (Saito, 2006; Sessa et al., 2008). All exper-
iments were conducted upon the approval and following the guidelines of an-
imal care and use committees from San Raffaele Scientific Institute (SRSI) and
Instituto Gulbenkian de Cie^ncia (IGC).(C) Top overrepresented motifs in 50-bp regions centered at MyT1 peak summit
(D) Examples of MyT1 (blue) and RBPJ (red) ChIP-seq enrichment profiles at vicinit
blue), and H3K27ac (green) ChIP-seq enrichment profiles are shown.
(E) Density plot of MyT1 (blue) and RBPJ (red) ChIP-seq reads at 4-kb genomic re
tag count) is shown.
(F) Validation of RBPJ binding to selected genes by ChIP-qPCR in NS5 cells is sho
(G) Validation of gene expression changes of selected genes in NS5 cells 4 hr af
Data are shown as mean ± SD; n.s., p > 0.05; *p < 0.05, **p < 0.01, ***p < 0.001, a
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NS5 (Conti et al., 2005) and NS5-Ascl1-ERT2 cells (Raposo et al., 2015) were
cultured in mouse Neurocult NSC basal medium supplemented with mouse
Neurocult NSC proliferation supplement (STEMCELL Technologies), peni-
cillin-streptomycin (100 U/mL) (Gibco), epidermal growth factor (EGF,
10 ng/mL) (PeproTech), basic FGF (10 ng/mL) (PeproTech), and laminin
(1 mg/mL) (Sigma-Aldrich). For expression profiling and ChIP, NS5-MyT1-
HA/GFP TetON cells were generated upon infection with MyT1-HA TetON-
FUW, eGFP TetON-FUW, and M2rtTA TetON-FUW lentiviruses and were
further expanded. When indicated, cells were treated with 50 nM Tam
(Sigma-Aldrich), 2 mg/mL Dox hyclate (Sigma-Aldrich), or 10 nM LY (Lanz
et al., 2004). Replication-incompetent lentiviruses were produced by transient
transfection of HEK293T cells with TetON-FUW vectors co-transfected with
psPAX2 and pCMV-VSVG. Lentiviral particles were concentrated from super-
natant by ultracentrifugation at 9,000 3 g for 4 hr and resuspended in 0.1%
BSA PBS.
Gene Expression, DNA Microarrays, and RNA-Seq
Gene expression analysis of cultured NS5 cells by real-time qPCR with
PerfeCTa SYBR Green FastMix, ROX (Quanta Biosciences) was carried out
according to the manufacturer’s instructions on an ABI7900 HT machine
(Applied Biosystems), using cDNA produced with High Capacity RNA-to-
cDNA Master Mix (Applied Biosystems) after Trizol RNA extraction (see the
Supplemental Experimental Procedures for primers). Microarray analysis
was performed on biological triplicates of NS5 MyT1-HA TetON cells 0 and
4 hr post-Dox induction. RNA concentration and purity were confirmed using
Agilent 2100 Bioanalyzer with RNA Nano Kit (Agilent Technologies). RNA
(100 ng) was processed with Ambion WT Expression Kit (Life Technologies)
and hybridized to the Affymetrix Mouse Gene 1.0 ST Array. CEL files were
analyzed using Chispter software (version 3.1.0, Kallio et al., 2011) using
RNA normalization and empirical Bayes two-group test with Benjamini-Hoch-
berg post hoc for p value correction. Samples used for RNA-seq analysis were
obtained from biological triplicates of NS5 0 and 4 hr post-LY treatment, and
total RNA was extracted as described above. The sequencing library was pre-
pared according to the TruSeq RNA sample preparation version 2 protocol
(Illumina) and sequenced on an Illumina HiSeq 2000. Raw reads were aligned
to NCBI37 (mm9) mouse genome using Tophat2 version 2.0.3 (Kim et al.,
2013). Pairwise analysis of differential gene expression was performed with
cuffdiff version 2.1.1 using fragment bias and multi-read corrections (Trapnell
et al., 2013). Genomic sequence and gene annotation were obtained from
ENSEMBL (May 2012, version 67).
ChIP and ChIP-Seq
Ascl1 ChIP from embryonic telencephalon was performed as previously
described (Castro et al., 2011). NS5 cells were fixed sequentially with 2 mM
di(N-succimidyl) glutarate and 1% formaldehyde in PBS and lysed, sonicated,
and immunoprecipitated as described previously (Castro et al., 2011), using
anti-HA (ab1424, Abcam), anti-Rbpj (D10A4, Cell Signaling Technology), or
anti-LSD1 (ab17721, Abcam) antibodies. DNA sequences were quantified by
real-time PCR (see the Supplemental Experimental Procedures for primers).
For sequencing, DNA libraries were prepared from 10 ng immunoprecipitated
DNA according to the manufacturer’s protocol. Paired-end sequencing was
performed using MySeq. Raw reads were mapped to the mouse genome
(NCBI37/mm9) with Bowtie version 0.12.7 (Langmead et al., 2009). Data
were processed further with MACS version 1.4.1 (Zhang et al., 2008) to define
the locations of BEs. Further details of data processing are described in the
Supplemental Experimental Procedures.s are shown. Z, Z score; R, enrichment ratio.
y of common bound genes and associated H3K4me3 (orange), H3K4me1 (dark
gions centered at MyT1 peak summits (signal intensity represents normalized
wn. ORF1 and ORF2, negative control regions. Mean ± SD of triplicate assays.
ter LY treatment by expression qPCR is shown.
nd ****p < 0.0001, according to Student’s t test (F and G). See also Figure S6.
In Vitro Binding and Transcriptional Assays
EMSAs were performed as described previously (Castro et al., 2006), using
probes (Supplemental Experimental Procedures) labeled with [g-32P] ATP
(PerkinElmer) using T4 polynucleotyde kinase (New England Biolabs). Control,
MyT1, andRBPJ proteins produced by coupled in vitro transcription and trans-
lation in rabbit reticulocyte lysates (TNT, Promega) were incubated with probe
in 20-mL binding reactions (15%glycerol, 20mMHEPES [pH 7.9], 5mMMgCl2,
50mMKCl, 0.1mMZnSO4, 0.01%Triton X-100, 10mMDTT, 5mMPMSF, and
0.2mg/uLherring spermDNA;Sigma-AldrichD7290) for 20minat room temper-
ature (RT). Reporter gene assays in transfected P19 cells were performed as
previously described (Castro et al., 2011). Oligonucleotides used to mutate
Hes1::Luc are described in the Supplemental Experimental Procedures.
Statistical Procedures
Where indicated, data from at least three (qPCR assays) or four (luciferase as-
says) biological replicates are presented as mean ± SD. For in utero electropo-
rations, >500 cells from at least three sections were counted, using three em-
bryos per condition. Differentiation in culture was scored counting >1,500 cells
from three coverslips per condition. In all cases, statistical significance was
calculated by performing a two-tailed, unpaired Student’s t test or one-way
ANOVA test with Bonferroni correction (see figure legends).
ACCESSION NUMBERS
The accession numbers for all genomic datasets reported in this paper are
Array Express (http://www.ebi.ac.uk/arrayexpress): E-MTAB-4330 (MyT1
ChIP-seq), E-MTAB-4494 (Rbpj ChIP-seq in NS5 cells), E-MTAB-4335
(MyT1 GoF in NS5 cell DNA arrays), and E-MTAB-4331 (RNA-seq from NS5
cells treated with LY).
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